| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Axons | 33 | 2023 | 1678 | 2.800 |
Why?
|
| Optic Disk | 32 | 2017 | 422 | 2.270 |
Why?
|
| Intraocular Pressure | 37 | 2018 | 1304 | 2.110 |
Why?
|
| Retinal Vessels | 20 | 2019 | 864 | 2.100 |
Why?
|
| Glaucoma | 32 | 2024 | 1194 | 1.950 |
Why?
|
| Optometry | 5 | 2021 | 29 | 1.870 |
Why?
|
| Retina | 24 | 2024 | 2661 | 1.700 |
Why?
|
| Ocular Hypertension | 11 | 2024 | 211 | 1.680 |
Why?
|
| Laser-Doppler Flowmetry | 16 | 2014 | 238 | 1.510 |
Why?
|
| Hypercapnia | 7 | 2014 | 260 | 1.360 |
Why?
|
| Glaucoma, Open-Angle | 16 | 2016 | 742 | 1.300 |
Why?
|
| Flicker Fusion | 6 | 2014 | 14 | 1.210 |
Why?
|
| Regional Blood Flow | 19 | 2019 | 1502 | 1.200 |
Why?
|
| Optical Illusions | 5 | 2014 | 40 | 1.130 |
Why?
|
| Retinal Ganglion Cells | 15 | 2024 | 811 | 1.110 |
Why?
|
| Visual Fields | 26 | 2021 | 1067 | 1.090 |
Why?
|
| Visual Field Tests | 21 | 2021 | 415 | 1.040 |
Why?
|
| Optic Nerve Diseases | 16 | 2018 | 342 | 1.030 |
Why?
|
| Superior Colliculi | 9 | 2008 | 98 | 1.020 |
Why?
|
| Astrocytes | 9 | 2024 | 1349 | 1.020 |
Why?
|
| Spinal Cord | 9 | 2016 | 1813 | 1.000 |
Why?
|
| Visual Pathways | 13 | 2008 | 559 | 0.990 |
Why?
|
| Growth Cones | 9 | 2014 | 117 | 0.950 |
Why?
|
| Optic Nerve | 11 | 2024 | 571 | 0.830 |
Why?
|
| Diabetic Retinopathy | 13 | 2019 | 1299 | 0.830 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 14 | 2002 | 1628 | 0.770 |
Why?
|
| Retinal Artery | 4 | 2015 | 109 | 0.710 |
Why?
|
| Embryo, Mammalian | 9 | 2013 | 1674 | 0.700 |
Why?
|
| Tomography | 14 | 2007 | 442 | 0.700 |
Why?
|
| Neuroglia | 4 | 2023 | 960 | 0.690 |
Why?
|
| Stress, Mechanical | 6 | 2017 | 1679 | 0.680 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 7 | 2015 | 251 | 0.640 |
Why?
|
| RNA-Binding Proteins | 5 | 2019 | 1883 | 0.640 |
Why?
|
| Ephrins | 5 | 2009 | 28 | 0.630 |
Why?
|
| Ganglia, Spinal | 5 | 2014 | 530 | 0.630 |
Why?
|
| Membrane Proteins | 17 | 2013 | 7885 | 0.620 |
Why?
|
| Sutures | 2 | 2017 | 283 | 0.620 |
Why?
|
| Blood Flow Velocity | 12 | 2016 | 1375 | 0.610 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 4 | 2018 | 21 | 0.610 |
Why?
|
| Photography | 4 | 2016 | 537 | 0.590 |
Why?
|
| Oxygen | 9 | 2019 | 4273 | 0.590 |
Why?
|
| Neurons | 13 | 2023 | 9512 | 0.570 |
Why?
|
| Ephrin-A2 | 14 | 2005 | 25 | 0.550 |
Why?
|
| Nerve Regeneration | 5 | 2023 | 799 | 0.540 |
Why?
|
| Ephrin-A5 | 12 | 2006 | 17 | 0.540 |
Why?
|
| Macular Edema | 6 | 2006 | 387 | 0.530 |
Why?
|
| RNA, Messenger | 11 | 2023 | 12801 | 0.530 |
Why?
|
| Receptors, Cell Surface | 8 | 2019 | 2819 | 0.530 |
Why?
|
| Form Perception | 3 | 2008 | 175 | 0.510 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 838 | 0.490 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 4 | 2011 | 142 | 0.480 |
Why?
|
| Body Patterning | 4 | 2009 | 634 | 0.480 |
Why?
|
| Chick Embryo | 8 | 2016 | 975 | 0.470 |
Why?
|
| Recombinant Fusion Proteins | 11 | 2009 | 3728 | 0.470 |
Why?
|
| Nerve Tissue Proteins | 7 | 2013 | 4414 | 0.460 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2014 | 36 | 0.450 |
Why?
|
| Arterioles | 6 | 2015 | 252 | 0.450 |
Why?
|
| Eye | 7 | 2014 | 713 | 0.450 |
Why?
|
| Sclera | 9 | 2017 | 189 | 0.450 |
Why?
|
| Proteoglycans | 4 | 2009 | 807 | 0.440 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2014 | 182 | 0.440 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 1406 | 0.420 |
Why?
|
| Aqueous Humor | 3 | 2019 | 152 | 0.420 |
Why?
|
| Animals | 81 | 2024 | 169322 | 0.400 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2016 | 3612 | 0.400 |
Why?
|
| Alkaline Phosphatase | 8 | 2003 | 864 | 0.390 |
Why?
|
| Protein Biosynthesis | 4 | 2023 | 2094 | 0.390 |
Why?
|
| Receptors, Eph Family | 6 | 2008 | 45 | 0.380 |
Why?
|
| Mice | 50 | 2024 | 82004 | 0.370 |
Why?
|
| Photic Stimulation | 6 | 2014 | 2004 | 0.370 |
Why?
|
| Neuregulin-1 | 1 | 2011 | 136 | 0.360 |
Why?
|
| Glaucoma, Angle-Closure | 2 | 2011 | 192 | 0.360 |
Why?
|
| Ligands | 19 | 2009 | 3283 | 0.350 |
Why?
|
| Lipoxins | 3 | 2024 | 419 | 0.350 |
Why?
|
| Lasers | 8 | 2013 | 952 | 0.350 |
Why?
|
| Mesencephalon | 4 | 2009 | 339 | 0.350 |
Why?
|
| GTPase-Activating Proteins | 3 | 2008 | 470 | 0.340 |
Why?
|
| Sensory Receptor Cells | 2 | 2011 | 508 | 0.340 |
Why?
|
| Light | 9 | 2013 | 1354 | 0.340 |
Why?
|
| Proteomics | 4 | 2022 | 3906 | 0.330 |
Why?
|
| Olfactory Bulb | 3 | 2007 | 198 | 0.330 |
Why?
|
| GTP-Binding Proteins | 3 | 2008 | 947 | 0.310 |
Why?
|
| Central Nervous System | 4 | 2023 | 1346 | 0.310 |
Why?
|
| Cell Adhesion Molecules, Neuron-Glia | 1 | 2008 | 2 | 0.310 |
Why?
|
| Microtubules | 1 | 2014 | 1073 | 0.310 |
Why?
|
| Nervous System | 4 | 2005 | 547 | 0.300 |
Why?
|
| Molecular Probes | 2 | 2000 | 309 | 0.300 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 2411 | 0.300 |
Why?
|
| Spinal Cord Injuries | 2 | 2009 | 929 | 0.300 |
Why?
|
| Ribosomal Proteins | 1 | 2010 | 370 | 0.290 |
Why?
|
| Neurogenesis | 1 | 2014 | 864 | 0.290 |
Why?
|
| Peripheral Nerves | 1 | 2011 | 492 | 0.290 |
Why?
|
| Cells, Cultured | 17 | 2014 | 19019 | 0.280 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2007 | 982 | 0.280 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2007 | 96 | 0.280 |
Why?
|
| Visual Acuity | 16 | 2019 | 2714 | 0.270 |
Why?
|
| Oximetry | 5 | 2019 | 462 | 0.270 |
Why?
|
| Anterior Chamber | 3 | 1999 | 194 | 0.270 |
Why?
|
| Gonioscopy | 2 | 1997 | 157 | 0.270 |
Why?
|
| Sensory Thresholds | 7 | 2008 | 377 | 0.270 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2008 | 263 | 0.260 |
Why?
|
| Embryo, Nonmammalian | 2 | 2000 | 911 | 0.260 |
Why?
|
| Capillaries | 7 | 2008 | 756 | 0.260 |
Why?
|
| Protein Binding | 11 | 2020 | 9346 | 0.260 |
Why?
|
| Contrast Sensitivity | 5 | 2008 | 253 | 0.250 |
Why?
|
| Receptor, EphA5 | 6 | 2006 | 10 | 0.250 |
Why?
|
| Scattering, Radiation | 3 | 2013 | 489 | 0.250 |
Why?
|
| Brain Mapping | 9 | 2005 | 6740 | 0.250 |
Why?
|
| Molecular Sequence Data | 18 | 2014 | 17626 | 0.250 |
Why?
|
| Tomography, Optical Coherence | 9 | 2019 | 2957 | 0.250 |
Why?
|
| Drosophila Proteins | 3 | 2006 | 1713 | 0.250 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2006 | 153 | 0.250 |
Why?
|
| Humans | 151 | 2024 | 768298 | 0.240 |
Why?
|
| Eyelid Diseases | 1 | 2007 | 157 | 0.240 |
Why?
|
| Cell Membrane | 10 | 2022 | 3663 | 0.240 |
Why?
|
| Protein Isoforms | 2 | 2011 | 1704 | 0.240 |
Why?
|
| Cat Diseases | 1 | 2024 | 32 | 0.230 |
Why?
|
| Base Sequence | 14 | 2014 | 12421 | 0.230 |
Why?
|
| In Situ Hybridization | 10 | 2014 | 1905 | 0.230 |
Why?
|
| Cloning, Molecular | 7 | 2001 | 4168 | 0.230 |
Why?
|
| Vision Disorders | 6 | 2021 | 1093 | 0.230 |
Why?
|
| Blood Pressure | 12 | 2024 | 8541 | 0.230 |
Why?
|
| Perceptual Masking | 1 | 2004 | 90 | 0.220 |
Why?
|
| Fibroblast Growth Factors | 1 | 2009 | 873 | 0.210 |
Why?
|
| Transcription Factors | 11 | 2014 | 12166 | 0.210 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 11914 | 0.210 |
Why?
|
| Proteome | 2 | 2019 | 1880 | 0.210 |
Why?
|
| Finite Element Analysis | 8 | 2017 | 442 | 0.210 |
Why?
|
| Male | 82 | 2024 | 364870 | 0.210 |
Why?
|
| Annexin A4 | 1 | 2022 | 9 | 0.210 |
Why?
|
| Nerve Growth Factors | 2 | 2010 | 564 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 7 | 2020 | 3779 | 0.200 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2008 | 1114 | 0.200 |
Why?
|
| Signal Transduction | 13 | 2019 | 23629 | 0.200 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 12775 | 0.190 |
Why?
|
| Tonometry, Ocular | 4 | 2017 | 238 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2010 | 2811 | 0.190 |
Why?
|
| Posture | 3 | 2017 | 956 | 0.190 |
Why?
|
| Schools, Health Occupations | 1 | 2020 | 6 | 0.190 |
Why?
|
| Visual Perception | 2 | 2014 | 1406 | 0.190 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 1094 | 0.190 |
Why?
|
| Ocular Physiological Phenomena | 2 | 2014 | 67 | 0.180 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 94 | 0.180 |
Why?
|
| Psychophysics | 3 | 2008 | 291 | 0.180 |
Why?
|
| Disintegrins | 1 | 2000 | 27 | 0.180 |
Why?
|
| Macula Lutea | 4 | 2005 | 180 | 0.180 |
Why?
|
| Transfection | 9 | 2006 | 5758 | 0.180 |
Why?
|
| Chemotactic Factors | 1 | 2001 | 197 | 0.180 |
Why?
|
| Myelin Proteins | 1 | 2001 | 212 | 0.170 |
Why?
|
| Receptor, EphA3 | 4 | 2005 | 13 | 0.170 |
Why?
|
| Neural Inhibition | 1 | 2004 | 588 | 0.170 |
Why?
|
| Receptors, Growth Factor | 3 | 1996 | 326 | 0.170 |
Why?
|
| Geniculate Bodies | 5 | 2005 | 159 | 0.170 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2020 | 156 | 0.170 |
Why?
|
| Adult | 57 | 2021 | 223622 | 0.170 |
Why?
|
| Cell Movement | 4 | 2014 | 5214 | 0.170 |
Why?
|
| Prosencephalon | 2 | 1999 | 306 | 0.170 |
Why?
|
| Female | 74 | 2024 | 397050 | 0.170 |
Why?
|
| Models, Biological | 12 | 2011 | 9494 | 0.170 |
Why?
|
| Phosphoproteins | 2 | 2015 | 2448 | 0.160 |
Why?
|
| Metalloendopeptidases | 2 | 2000 | 385 | 0.160 |
Why?
|
| Fourier Analysis | 3 | 2014 | 440 | 0.160 |
Why?
|
| Somatosensory Cortex | 2 | 2000 | 516 | 0.160 |
Why?
|
| Host Cell Factor C1 | 1 | 2019 | 35 | 0.160 |
Why?
|
| Proteins | 6 | 2000 | 6006 | 0.160 |
Why?
|
| Peptide Initiation Factors | 2 | 2012 | 53 | 0.160 |
Why?
|
| Sperm Motility | 1 | 2020 | 266 | 0.160 |
Why?
|
| Professional Practice | 1 | 2021 | 314 | 0.160 |
Why?
|
| Biochemistry | 1 | 2000 | 116 | 0.160 |
Why?
|
| Heparitin Sulfate | 2 | 2018 | 224 | 0.160 |
Why?
|
| Health Surveys | 4 | 2021 | 4056 | 0.160 |
Why?
|
| Proto-Oncogenes | 2 | 1990 | 322 | 0.160 |
Why?
|
| Laser Coagulation | 3 | 2011 | 333 | 0.160 |
Why?
|
| Rhombencephalon | 2 | 1995 | 81 | 0.150 |
Why?
|
| Limbus Corneae | 2 | 2017 | 144 | 0.150 |
Why?
|
| Orbital Neoplasms | 3 | 1989 | 223 | 0.150 |
Why?
|
| Amino Acid Sequence | 13 | 2011 | 13425 | 0.150 |
Why?
|
| Aged | 48 | 2021 | 171544 | 0.150 |
Why?
|
| Chromatography, Liquid | 2 | 2012 | 997 | 0.150 |
Why?
|
| Corneal Topography | 1 | 1998 | 69 | 0.150 |
Why?
|
| Fundus Oculi | 4 | 2006 | 560 | 0.150 |
Why?
|
| Cell Line | 10 | 2014 | 15593 | 0.150 |
Why?
|
| Heparan Sulfate Proteoglycans | 2 | 2011 | 111 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 12 | 2024 | 22355 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2014 | 3794 | 0.150 |
Why?
|
| Curriculum | 2 | 2022 | 3775 | 0.140 |
Why?
|
| Light Coagulation | 1 | 2017 | 72 | 0.140 |
Why?
|
| Stem Cells | 4 | 2008 | 3537 | 0.140 |
Why?
|
| Thinking | 1 | 2020 | 320 | 0.140 |
Why?
|
| Retinal Diseases | 3 | 2017 | 710 | 0.140 |
Why?
|
| Glaucoma Drainage Implants | 2 | 2008 | 107 | 0.140 |
Why?
|
| Problem-Based Learning | 1 | 2020 | 356 | 0.140 |
Why?
|
| Carbonic Anhydrase Inhibitors | 2 | 2009 | 91 | 0.140 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2016 | 53 | 0.140 |
Why?
|
| Neurons, Afferent | 2 | 2011 | 498 | 0.140 |
Why?
|
| Withanolides | 1 | 2016 | 10 | 0.140 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 1996 | 7 | 0.140 |
Why?
|
| Electroretinography | 2 | 2017 | 524 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 2003 | 0.130 |
Why?
|
| COS Cells | 5 | 2009 | 1135 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 4357 | 0.130 |
Why?
|
| Circadian Rhythm | 5 | 2011 | 2588 | 0.130 |
Why?
|
| Retinal Neurons | 1 | 2016 | 67 | 0.130 |
Why?
|
| Glycosylphosphatidylinositols | 3 | 2009 | 88 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2009 | 3736 | 0.130 |
Why?
|
| Teaching | 2 | 2020 | 1172 | 0.130 |
Why?
|
| Administration, Topical | 4 | 2014 | 703 | 0.130 |
Why?
|
| Retinal Vein Occlusion | 1 | 2017 | 149 | 0.130 |
Why?
|
| RNA Interference | 2 | 2019 | 2836 | 0.130 |
Why?
|
| Endothelial Growth Factors | 2 | 1996 | 674 | 0.130 |
Why?
|
| Models, Neurological | 6 | 2007 | 1783 | 0.130 |
Why?
|
| Carbon Dioxide | 3 | 2014 | 1149 | 0.130 |
Why?
|
| Clinical Clerkship | 1 | 2022 | 566 | 0.130 |
Why?
|
| Microglia | 1 | 2024 | 1374 | 0.130 |
Why?
|
| Endothelin-1 | 1 | 2017 | 296 | 0.130 |
Why?
|
| Gliosis | 1 | 2016 | 246 | 0.130 |
Why?
|
| Protein Subunits | 1 | 2019 | 943 | 0.130 |
Why?
|
| Xenopus laevis | 1 | 2019 | 966 | 0.130 |
Why?
|
| Contact Lenses | 1 | 2017 | 137 | 0.120 |
Why?
|
| Electroporation | 1 | 2016 | 236 | 0.120 |
Why?
|
| Lymphokines | 2 | 1996 | 927 | 0.120 |
Why?
|
| Cell Communication | 5 | 2006 | 1660 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2018 | 3139 | 0.120 |
Why?
|
| Proton Pump Inhibitors | 1 | 2020 | 553 | 0.120 |
Why?
|
| RGS Proteins | 3 | 2008 | 76 | 0.120 |
Why?
|
| Protein Folding | 2 | 2018 | 872 | 0.120 |
Why?
|
| Receptor, EphA2 | 3 | 2005 | 41 | 0.120 |
Why?
|
| Disease Progression | 6 | 2018 | 13646 | 0.120 |
Why?
|
| RNA Polymerase II | 1 | 2019 | 547 | 0.120 |
Why?
|
| Middle Aged | 49 | 2021 | 223463 | 0.120 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1994 | 98 | 0.120 |
Why?
|
| Body Composition | 1 | 2024 | 2461 | 0.120 |
Why?
|
| Refractive Errors | 1 | 1996 | 148 | 0.120 |
Why?
|
| Fetal Proteins | 1 | 1994 | 99 | 0.120 |
Why?
|
| Computer Simulation | 9 | 2017 | 6277 | 0.110 |
Why?
|
| Axotomy | 1 | 2014 | 71 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2003 | 2574 | 0.110 |
Why?
|
| Vision, Ocular | 3 | 2005 | 458 | 0.110 |
Why?
|
| Prosthesis Implantation | 2 | 2008 | 594 | 0.110 |
Why?
|
| Cataract | 2 | 2013 | 837 | 0.110 |
Why?
|
| Evoked Potentials, Visual | 4 | 1990 | 420 | 0.110 |
Why?
|
| National Health Programs | 1 | 2017 | 442 | 0.110 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 1988 | 648 | 0.110 |
Why?
|
| Ophthalmic Solutions | 3 | 2012 | 312 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2001 | 2750 | 0.110 |
Why?
|
| Neurocan | 2 | 2011 | 21 | 0.110 |
Why?
|
| Reference Values | 8 | 2015 | 4941 | 0.110 |
Why?
|
| Amino Acid Motifs | 2 | 2010 | 928 | 0.110 |
Why?
|
| Health Services Research | 1 | 2021 | 1817 | 0.110 |
Why?
|
| Nerve Net | 1 | 2006 | 2362 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2011 | 5033 | 0.110 |
Why?
|
| Ephrin-A3 | 2 | 2005 | 6 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 3 | 1991 | 4526 | 0.110 |
Why?
|
| Antihypertensive Agents | 4 | 2012 | 2027 | 0.110 |
Why?
|
| Retinal Vein | 1 | 2013 | 47 | 0.110 |
Why?
|
| Neural Pathways | 5 | 2011 | 3121 | 0.110 |
Why?
|
| Venules | 1 | 2013 | 161 | 0.110 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2013 | 89 | 0.110 |
Why?
|
| Musculoskeletal System | 1 | 1995 | 188 | 0.110 |
Why?
|
| Heart Rate | 3 | 2024 | 4218 | 0.110 |
Why?
|
| Sensitivity and Specificity | 10 | 2021 | 14736 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 369 | 0.110 |
Why?
|
| Chondroitin Sulfates | 2 | 2011 | 174 | 0.100 |
Why?
|
| Apoptosis | 3 | 2016 | 9506 | 0.100 |
Why?
|
| Thiophenes | 2 | 2009 | 569 | 0.100 |
Why?
|
| Rats | 6 | 2014 | 23833 | 0.100 |
Why?
|
| Binding Sites | 4 | 2011 | 6018 | 0.100 |
Why?
|
| Oxygen Consumption | 2 | 2016 | 1882 | 0.100 |
Why?
|
| Ephrin-B1 | 4 | 2001 | 24 | 0.100 |
Why?
|
| Ribosomes | 2 | 2019 | 499 | 0.100 |
Why?
|
| Weight Loss | 1 | 2024 | 2715 | 0.100 |
Why?
|
| Vision, Low | 2 | 1994 | 163 | 0.100 |
Why?
|
| Thalamus | 4 | 2003 | 1050 | 0.100 |
Why?
|
| Multigene Family | 1 | 1995 | 1082 | 0.100 |
Why?
|
| Timolol | 1 | 2012 | 51 | 0.100 |
Why?
|
| Pattern Recognition, Visual | 3 | 2008 | 825 | 0.100 |
Why?
|
| Reproducibility of Results | 9 | 2014 | 20224 | 0.100 |
Why?
|
| Protein Conformation | 3 | 2013 | 3957 | 0.100 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 461 | 0.090 |
Why?
|
| Echocardiography | 1 | 2024 | 5044 | 0.090 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 1082 | 0.090 |
Why?
|
| Sequence Alignment | 2 | 2014 | 2177 | 0.090 |
Why?
|
| Polysaccharides | 1 | 2018 | 1024 | 0.090 |
Why?
|
| Aggrecans | 2 | 2009 | 89 | 0.090 |
Why?
|
| Disposable Equipment | 1 | 2011 | 46 | 0.090 |
Why?
|
| Genetic Vectors | 4 | 2004 | 3411 | 0.090 |
Why?
|
| Lasers, Semiconductor | 1 | 2011 | 43 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 3436 | 0.090 |
Why?
|
| Neurites | 2 | 2011 | 390 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 957 | 0.090 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2011 | 54 | 0.090 |
Why?
|
| Cell-Free System | 3 | 2001 | 340 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2004 | 6238 | 0.090 |
Why?
|
| Tubulin | 1 | 2014 | 694 | 0.090 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 542 | 0.090 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2017 | 1735 | 0.090 |
Why?
|
| Ciliary Body | 1 | 2011 | 168 | 0.090 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 1990 | 27 | 0.090 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 1990 | 22 | 0.090 |
Why?
|
| Microscopy | 1 | 1995 | 909 | 0.090 |
Why?
|
| Organogenesis | 1 | 2011 | 214 | 0.090 |
Why?
|
| 3T3 Cells | 5 | 2001 | 1086 | 0.090 |
Why?
|
| Receptor, EphA4 | 2 | 2003 | 17 | 0.090 |
Why?
|
| GPI-Linked Proteins | 2 | 2002 | 473 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2012 | 731 | 0.090 |
Why?
|
| Facial Expression | 1 | 2014 | 515 | 0.080 |
Why?
|
| Dioxygenases | 1 | 2012 | 351 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2006 | 458 | 0.080 |
Why?
|
| Tectum Mesencephali | 1 | 2009 | 18 | 0.080 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2009 | 196 | 0.080 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 18358 | 0.080 |
Why?
|
| Biological Assay | 2 | 2004 | 627 | 0.080 |
Why?
|
| Histone Demethylases | 1 | 2012 | 322 | 0.080 |
Why?
|
| Mice, Knockout | 9 | 2014 | 14481 | 0.080 |
Why?
|
| Pancreas | 1 | 1996 | 1701 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2004 | 6606 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2009 | 114 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2004 | 1524 | 0.080 |
Why?
|
| Cryoelectron Microscopy | 1 | 2013 | 647 | 0.080 |
Why?
|
| Ephrin-B2 | 2 | 2001 | 40 | 0.080 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2008 | 32 | 0.080 |
Why?
|
| Sphingomyelins | 1 | 2009 | 105 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1705 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1492 | 0.080 |
Why?
|
| Gene Fusion | 1 | 2011 | 356 | 0.080 |
Why?
|
| Anterior Eye Segment | 1 | 2009 | 144 | 0.080 |
Why?
|
| Partial Pressure | 1 | 2008 | 248 | 0.080 |
Why?
|
| Contactins | 1 | 2008 | 21 | 0.080 |
Why?
|
| Ephrin-B3 | 2 | 1998 | 12 | 0.080 |
Why?
|
| Optic Chiasm | 1 | 1988 | 91 | 0.080 |
Why?
|
| Tissue Culture Techniques | 1 | 2009 | 290 | 0.080 |
Why?
|
| Cytokines | 2 | 2024 | 7443 | 0.080 |
Why?
|
| Glare | 1 | 2007 | 6 | 0.070 |
Why?
|
| Sleep | 2 | 2017 | 4802 | 0.070 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2008 | 44 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4940 | 0.070 |
Why?
|
| Tears | 1 | 2009 | 252 | 0.070 |
Why?
|
| Chickens | 4 | 2002 | 845 | 0.070 |
Why?
|
| Publication Bias | 1 | 2008 | 159 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 5800 | 0.070 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1988 | 289 | 0.070 |
Why?
|
| Sulfonamides | 2 | 2009 | 1980 | 0.070 |
Why?
|
| Dendrites | 1 | 2010 | 472 | 0.070 |
Why?
|
| Cell Adhesion | 3 | 2001 | 3101 | 0.070 |
Why?
|
| Mydriatics | 1 | 2007 | 67 | 0.070 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2009 | 450 | 0.070 |
Why?
|
| Aging | 4 | 2014 | 8764 | 0.070 |
Why?
|
| Chromatin | 1 | 2019 | 2967 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2009 | 425 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 731 | 0.070 |
Why?
|
| Nerve Compression Syndromes | 1 | 1988 | 160 | 0.070 |
Why?
|
| Gene Expression | 7 | 2002 | 7595 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2008 | 11659 | 0.070 |
Why?
|
| Receptors, Odorant | 1 | 2006 | 67 | 0.070 |
Why?
|
| Drugs, Generic | 1 | 2012 | 454 | 0.070 |
Why?
|
| Diagnostic Imaging | 2 | 2015 | 3541 | 0.070 |
Why?
|
| Pupil | 1 | 2007 | 146 | 0.070 |
Why?
|
| RNA | 4 | 2002 | 2726 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2017 | 12239 | 0.070 |
Why?
|
| RNA Splicing | 1 | 1991 | 903 | 0.070 |
Why?
|
| Cell Death | 1 | 2011 | 1681 | 0.070 |
Why?
|
| Liposarcoma | 1 | 1989 | 289 | 0.070 |
Why?
|
| Restriction Mapping | 2 | 2001 | 849 | 0.060 |
Why?
|
| Insurance Coverage | 1 | 2017 | 1946 | 0.060 |
Why?
|
| Aged, 80 and over | 15 | 2017 | 59683 | 0.060 |
Why?
|
| Crystallography, X-Ray | 3 | 2018 | 1956 | 0.060 |
Why?
|
| Vascular Resistance | 1 | 2008 | 940 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1197 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 4 | 2011 | 6084 | 0.060 |
Why?
|
| Uveitis | 2 | 2008 | 398 | 0.060 |
Why?
|
| False Positive Reactions | 2 | 2007 | 962 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 2201 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 3 | 1996 | 725 | 0.060 |
Why?
|
| Elastic Modulus | 3 | 2010 | 211 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4847 | 0.060 |
Why?
|
| Macular Degeneration | 3 | 1998 | 1016 | 0.060 |
Why?
|
| Gene Library | 2 | 2000 | 1061 | 0.060 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2006 | 389 | 0.060 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1984 | 8 | 0.060 |
Why?
|
| Prescription Drugs | 1 | 2012 | 634 | 0.060 |
Why?
|
| Insulin | 1 | 2019 | 6608 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2015 | 2103 | 0.060 |
Why?
|
| Canada | 4 | 2017 | 2139 | 0.060 |
Why?
|
| Nerve Fibers | 2 | 2005 | 709 | 0.060 |
Why?
|
| Adenoma | 2 | 1988 | 2163 | 0.060 |
Why?
|
| Research Support as Topic | 1 | 2008 | 696 | 0.060 |
Why?
|
| Ephrin-A4 | 1 | 2003 | 2 | 0.060 |
Why?
|
| Body Temperature | 1 | 2007 | 781 | 0.060 |
Why?
|
| Young Adult | 8 | 2015 | 60048 | 0.060 |
Why?
|
| Prospective Studies | 10 | 2024 | 54921 | 0.050 |
Why?
|
| Synapses | 2 | 2006 | 1766 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2017 | 9380 | 0.050 |
Why?
|
| Conjunctiva | 1 | 2007 | 474 | 0.050 |
Why?
|
| Conflict of Interest | 1 | 2008 | 555 | 0.050 |
Why?
|
| Biotin | 1 | 2004 | 256 | 0.050 |
Why?
|
| Interferometry | 1 | 2003 | 101 | 0.050 |
Why?
|
| Liver | 1 | 2019 | 7570 | 0.050 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 39405 | 0.050 |
Why?
|
| Hemangioma, Cavernous | 1 | 1983 | 107 | 0.050 |
Why?
|
| Sindbis Virus | 1 | 2002 | 36 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 9563 | 0.050 |
Why?
|
| Cats | 1 | 2024 | 978 | 0.050 |
Why?
|
| Exophthalmos | 1 | 1983 | 100 | 0.050 |
Why?
|
| Age Factors | 4 | 2015 | 18472 | 0.050 |
Why?
|
| Observer Variation | 3 | 2014 | 2623 | 0.050 |
Why?
|
| GAP-43 Protein | 1 | 2002 | 152 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2003 | 320 | 0.050 |
Why?
|
| Synaptic Transmission | 2 | 2006 | 1175 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2014 | 1986 | 0.050 |
Why?
|
| Lacrimal Apparatus Diseases | 2 | 1998 | 72 | 0.050 |
Why?
|
| Respiratory Mechanics | 1 | 2006 | 722 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 17132 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 10776 | 0.050 |
Why?
|
| Microspheres | 1 | 2005 | 789 | 0.050 |
Why?
|
| Automobile Driving | 1 | 2007 | 442 | 0.050 |
Why?
|
| Drug Industry | 1 | 2008 | 793 | 0.050 |
Why?
|
| Time Factors | 7 | 2019 | 40267 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 2911 | 0.050 |
Why?
|
| Obesity | 1 | 2024 | 13082 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 2950 | 0.050 |
Why?
|
| Primates | 1 | 2024 | 521 | 0.050 |
Why?
|
| Mass Screening | 1 | 2017 | 5451 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2009 | 4076 | 0.050 |
Why?
|
| Meningioma | 1 | 1990 | 1221 | 0.050 |
Why?
|
| Particle Size | 1 | 2005 | 1653 | 0.050 |
Why?
|
| Ontario | 3 | 2011 | 403 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 1629 | 0.050 |
Why?
|
| Meningeal Neoplasms | 1 | 1990 | 1253 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 1755 | 0.050 |
Why?
|
| Eye Enucleation | 3 | 2009 | 128 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2004 | 841 | 0.040 |
Why?
|
| Genes | 2 | 2000 | 1824 | 0.040 |
Why?
|
| Cartilage, Articular | 2 | 1998 | 1104 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1995 | 2846 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2004 | 4175 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2002 | 515 | 0.040 |
Why?
|
| Mutation | 4 | 2000 | 30230 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 2429 | 0.040 |
Why?
|
| DNA | 5 | 2008 | 7211 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2015 | 8072 | 0.040 |
Why?
|
| Pituitary Neoplasms | 1 | 1988 | 1325 | 0.040 |
Why?
|
| Osteoarthritis | 2 | 1998 | 1070 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1496 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 839 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 26373 | 0.040 |
Why?
|
| Papilloma | 1 | 1980 | 143 | 0.040 |
Why?
|
| Spinal Nerves | 1 | 1999 | 92 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 2001 | 420 | 0.040 |
Why?
|
| Immunohistochemistry | 6 | 2014 | 11117 | 0.040 |
Why?
|
| Cerebellum | 2 | 2004 | 1514 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 816 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2001 | 457 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2002 | 1163 | 0.040 |
Why?
|
| Xenopus | 1 | 2001 | 710 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2009 | 9063 | 0.040 |
Why?
|
| Iridocyclitis | 1 | 1998 | 11 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2014 | 610 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2011 | 2855 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 6034 | 0.040 |
Why?
|
| Random Allocation | 2 | 1993 | 2397 | 0.040 |
Why?
|
| Hippocampus | 2 | 2010 | 3784 | 0.040 |
Why?
|
| Cytoplasm | 2 | 2001 | 1500 | 0.040 |
Why?
|
| Facial Hemiatrophy | 1 | 1998 | 24 | 0.040 |
Why?
|
| Retroviridae | 2 | 2002 | 849 | 0.040 |
Why?
|
| Enophthalmos | 1 | 1998 | 34 | 0.040 |
Why?
|
| Choline | 1 | 2020 | 518 | 0.040 |
Why?
|
| Prostaglandins, Synthetic | 1 | 1998 | 24 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2003 | 770 | 0.040 |
Why?
|
| Sleep, REM | 1 | 2001 | 595 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 1996 | 2433 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 1614 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1998 | 1553 | 0.040 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2001 | 277 | 0.040 |
Why?
|
| Optics and Photonics | 2 | 2000 | 307 | 0.040 |
Why?
|
| Retinitis Pigmentosa | 1 | 2001 | 395 | 0.040 |
Why?
|
| Biological Evolution | 1 | 1984 | 1079 | 0.040 |
Why?
|
| Cues | 1 | 2003 | 884 | 0.040 |
Why?
|
| Prince Edward Island | 1 | 2017 | 1 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 2433 | 0.040 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1998 | 174 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 1684 | 0.040 |
Why?
|
| Bandages | 1 | 1999 | 273 | 0.040 |
Why?
|
| Trabeculectomy | 1 | 1999 | 174 | 0.040 |
Why?
|
| N-Methylaspartate | 1 | 1998 | 231 | 0.040 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 1998 | 138 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2020 | 1216 | 0.040 |
Why?
|
| Smoking | 1 | 2014 | 9109 | 0.040 |
Why?
|
| Education, Distance | 1 | 2020 | 261 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2001 | 607 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2004 | 4137 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2008 | 5151 | 0.030 |
Why?
|
| Fishes | 1 | 2000 | 606 | 0.030 |
Why?
|
| Acute Disease | 2 | 2017 | 7242 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 2068 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2009 | 9681 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 1996 | 750 | 0.030 |
Why?
|
| Trabecular Meshwork | 1 | 1997 | 101 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2000 | 552 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2000 | 1992 | 0.030 |
Why?
|
| Drosophila | 2 | 2006 | 1514 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2000 | 628 | 0.030 |
Why?
|
| Cell Division | 3 | 1999 | 4478 | 0.030 |
Why?
|
| Anisotropy | 2 | 2010 | 1296 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2020 | 631 | 0.030 |
Why?
|
| Algorithms | 5 | 2021 | 14154 | 0.030 |
Why?
|
| Intermediate Filaments | 1 | 2016 | 171 | 0.030 |
Why?
|
| Polymerization | 1 | 2016 | 156 | 0.030 |
Why?
|
| Risk Factors | 5 | 2018 | 74954 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2000 | 1229 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 2000 | 2298 | 0.030 |
Why?
|
| Universities | 1 | 2021 | 1005 | 0.030 |
Why?
|
| Lenses | 1 | 1995 | 42 | 0.030 |
Why?
|
| Retinal Perforations | 1 | 1997 | 138 | 0.030 |
Why?
|
| Ireland | 1 | 2015 | 170 | 0.030 |
Why?
|
| Heparin Lyase | 1 | 1995 | 37 | 0.030 |
Why?
|
| Horseradish Peroxidase | 2 | 2006 | 170 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 508 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 881 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1995 | 48 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 6132 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 562 | 0.030 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 1998 | 366 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 3712 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 1996 | 223 | 0.030 |
Why?
|
| Sepharose | 1 | 1995 | 102 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 1451 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 1996 | 664 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2000 | 872 | 0.030 |
Why?
|
| United States | 2 | 2021 | 73144 | 0.030 |
Why?
|
| Rana pipiens | 2 | 2004 | 64 | 0.030 |
Why?
|
| Kinetics | 2 | 2000 | 6334 | 0.030 |
Why?
|
| Phosphorylation | 4 | 2015 | 8326 | 0.030 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2015 | 133 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2020 | 1142 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2014 | 139 | 0.030 |
Why?
|
| Edema | 1 | 1998 | 766 | 0.030 |
Why?
|
| Pseudotumor Cerebri | 1 | 1995 | 107 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 1999 | 1155 | 0.030 |
Why?
|
| Stem Cell Factor | 1 | 1994 | 194 | 0.030 |
Why?
|
| Equipment Design | 2 | 2007 | 3529 | 0.030 |
Why?
|
| Models, Anatomic | 2 | 2008 | 684 | 0.030 |
Why?
|
| Vision, Binocular | 1 | 1995 | 225 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 420 | 0.030 |
Why?
|
| Prevalence | 3 | 2015 | 15868 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2005 | 6512 | 0.030 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 1993 | 53 | 0.030 |
Why?
|
| Markov Chains | 1 | 2017 | 977 | 0.030 |
Why?
|
| Endopeptidases | 1 | 1997 | 766 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2020 | 1256 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2931 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 691 | 0.030 |
Why?
|
| Corneal Edema | 1 | 1993 | 45 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1994 | 866 | 0.030 |
Why?
|
| Chromosome Deletion | 2 | 1991 | 1390 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 614 | 0.030 |
Why?
|
| Veins | 1 | 2017 | 768 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1997 | 835 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2001 | 1448 | 0.030 |
Why?
|
| Brain | 4 | 2014 | 27452 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 12092 | 0.030 |
Why?
|
| Learning Curve | 1 | 2014 | 225 | 0.030 |
Why?
|
| Pia Mater | 1 | 2012 | 87 | 0.030 |
Why?
|
| Age of Onset | 2 | 2015 | 3345 | 0.030 |
Why?
|
| Surface Tension | 1 | 2012 | 43 | 0.020 |
Why?
|
| Drug Packaging | 1 | 2012 | 44 | 0.020 |
Why?
|
| Learning | 1 | 2022 | 1760 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2000 | 2204 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1998 | 1244 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1218 | 0.020 |
Why?
|
| Schools | 1 | 2021 | 1496 | 0.020 |
Why?
|
| Phylogeny | 2 | 2000 | 2842 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1998 | 3776 | 0.020 |
Why?
|
| Therapeutic Equivalency | 1 | 2012 | 134 | 0.020 |
Why?
|
| Probability | 1 | 2017 | 2482 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2005 | 6001 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2015 | 1890 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2004 | 3440 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 2008 | 5830 | 0.020 |
Why?
|
| Eye Diseases | 1 | 1997 | 657 | 0.020 |
Why?
|
| Endothelium, Vascular | 2 | 2010 | 4427 | 0.020 |
Why?
|
| Viscosity | 1 | 2012 | 336 | 0.020 |
Why?
|
| Glypicans | 1 | 2011 | 33 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 159 | 0.020 |
Why?
|
| Thymidine | 1 | 1991 | 297 | 0.020 |
Why?
|
| Postural Balance | 1 | 1995 | 639 | 0.020 |
Why?
|
| Heart | 1 | 2024 | 4449 | 0.020 |
Why?
|
| Escherichia coli | 2 | 2001 | 4209 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2011 | 270 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2024 | 6409 | 0.020 |
Why?
|
| Neuromuscular Junction | 2 | 2006 | 407 | 0.020 |
Why?
|
| Herpes Zoster Ophthalmicus | 1 | 1990 | 37 | 0.020 |
Why?
|
| Color Perception Tests | 1 | 1990 | 12 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 1990 | 6228 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2106 | 0.020 |
Why?
|
| Computers | 4 | 1986 | 592 | 0.020 |
Why?
|
| Imidazoles | 1 | 2016 | 1168 | 0.020 |
Why?
|
| Exfoliation Syndrome | 1 | 2011 | 113 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1151 | 0.020 |
Why?
|
| Protein Multimerization | 2 | 2011 | 972 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 13019 | 0.020 |
Why?
|
| Medical Records | 1 | 2015 | 1413 | 0.020 |
Why?
|
| Fluorescein Angiography | 2 | 2006 | 1086 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1992 | 595 | 0.020 |
Why?
|
| Cell Survival | 1 | 1999 | 5792 | 0.020 |
Why?
|
| Retinal Hemorrhage | 1 | 2010 | 98 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2010 | 335 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2009 | 159 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2009 | 208 | 0.020 |
Why?
|
| Gait | 1 | 1994 | 822 | 0.020 |
Why?
|
| Calcium | 1 | 2022 | 5794 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2005 | 10464 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 1209 | 0.020 |
Why?
|
| Case-Control Studies | 4 | 2015 | 22292 | 0.020 |
Why?
|
| Cloprostenol | 1 | 2008 | 21 | 0.020 |
Why?
|
| Color Perception | 1 | 1990 | 213 | 0.020 |
Why?
|
| Growth Substances | 1 | 1991 | 761 | 0.020 |
Why?
|
| Kidney | 1 | 2004 | 7063 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4286 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 1996 | 1371 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2000 | 4774 | 0.020 |
Why?
|
| Hyperoxia | 1 | 2010 | 261 | 0.020 |
Why?
|
| DNA-Binding Proteins | 4 | 2006 | 9618 | 0.020 |
Why?
|
| Regression Analysis | 3 | 1998 | 6350 | 0.020 |
Why?
|
| Functional Laterality | 2 | 2005 | 2268 | 0.020 |
Why?
|
| Cadaver | 1 | 2012 | 1366 | 0.020 |
Why?
|
| Mast Cells | 2 | 1996 | 1407 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 198 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2005 | 2695 | 0.020 |
Why?
|
| Tropicamide | 1 | 2007 | 22 | 0.020 |
Why?
|
| Optic Neuritis | 1 | 1990 | 175 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2011 | 678 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 1967 | 0.020 |
Why?
|
| Diplopia | 1 | 1989 | 217 | 0.020 |
Why?
|
| Thermometers | 1 | 2007 | 42 | 0.020 |
Why?
|
| Phenotype | 3 | 2000 | 16716 | 0.020 |
Why?
|
| Walking | 1 | 1994 | 1201 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2017 | 1959 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 1996 | 3520 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2007 | 292 | 0.020 |
Why?
|
| Journal Impact Factor | 1 | 2008 | 156 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2007 | 293 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2001 | 1769 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4584 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 1084 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 2008 | 15854 | 0.020 |
Why?
|
| Competitive Bidding | 1 | 2006 | 16 | 0.020 |
Why?
|
| Vasodilation | 1 | 2010 | 968 | 0.020 |
Why?
|
| Syndecans | 1 | 2006 | 75 | 0.020 |
Why?
|
| Computational Biology | 2 | 2008 | 3541 | 0.020 |
Why?
|
| Amides | 1 | 2008 | 452 | 0.020 |
Why?
|
| Receptor, EphB2 | 2 | 1996 | 31 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2015 | 1802 | 0.020 |
Why?
|
| Surface Properties | 1 | 1988 | 1166 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2011 | 2889 | 0.020 |
Why?
|
| Adolescent | 8 | 2015 | 89182 | 0.020 |
Why?
|
| Scalp | 1 | 1988 | 391 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 2524 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2008 | 81768 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2004 | 1926 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2014 | 2389 | 0.010 |
Why?
|
| Pyridines | 1 | 2016 | 2889 | 0.010 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 369 | 0.010 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1984 | 52 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1980 | 4069 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2006 | 293 | 0.010 |
Why?
|
| Semaphorins | 1 | 2004 | 96 | 0.010 |
Why?
|
| Heparin | 1 | 1992 | 1636 | 0.010 |
Why?
|
| Family | 1 | 2015 | 3208 | 0.010 |
Why?
|
| Nuclear Proteins | 2 | 1996 | 5802 | 0.010 |
Why?
|
| Larva | 1 | 2006 | 514 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5538 | 0.010 |
Why?
|
| Affinity Labels | 1 | 2003 | 107 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 691 | 0.010 |
Why?
|
| Head | 1 | 2010 | 927 | 0.010 |
Why?
|
| Gene Conversion | 1 | 1984 | 69 | 0.010 |
Why?
|
| DNA Replication | 1 | 1991 | 1429 | 0.010 |
Why?
|
| Infection Control | 1 | 2011 | 985 | 0.010 |
Why?
|
| Hemangiopericytoma | 1 | 1983 | 71 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1988 | 710 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 5 | 1998 | 20766 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 1739 | 0.010 |
Why?
|
| Dacryocystitis | 1 | 1983 | 68 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 2005 | 562 | 0.010 |
Why?
|
| Elasticity | 1 | 2004 | 657 | 0.010 |
Why?
|
| Dextrans | 1 | 2004 | 574 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2004 | 796 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2011 | 8730 | 0.010 |
Why?
|
| Codon | 1 | 1984 | 599 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2006 | 747 | 0.010 |
Why?
|
| Emotions | 1 | 2014 | 2768 | 0.010 |
Why?
|
| Reaction Time | 1 | 1988 | 2103 | 0.010 |
Why?
|
| Postoperative Care | 2 | 1999 | 1479 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2008 | 1174 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10656 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2002 | 228 | 0.010 |
Why?
|
| Epitopes | 2 | 1998 | 2525 | 0.010 |
Why?
|
| Camptothecin | 1 | 2004 | 593 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5408 | 0.010 |
Why?
|
| Photoreceptor Cells | 1 | 2001 | 234 | 0.010 |
Why?
|
| Inferior Colliculi | 1 | 2001 | 79 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2004 | 1760 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2010 | 36849 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2010 | 4199 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 326 | 0.010 |
Why?
|
| Lysine | 1 | 2004 | 988 | 0.010 |
Why?
|
| Vibrissae | 1 | 2000 | 123 | 0.010 |
Why?
|
| Auditory Pathways | 1 | 2001 | 238 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2000 | 438 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2000 | 1056 | 0.010 |
Why?
|
| Fluorometholone | 1 | 1998 | 5 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2000 | 327 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2010 | 3579 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 4450 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 2078 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 1988 | 2588 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1983 | 534 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 968 | 0.010 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 1469 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 1966 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 1996 | 121 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 15455 | 0.010 |
Why?
|
| Receptor, EphB5 | 1 | 1996 | 1 | 0.010 |
Why?
|
| Orbital Diseases | 1 | 1998 | 178 | 0.010 |
Why?
|
| Receptor, EphB3 | 1 | 1996 | 11 | 0.010 |
Why?
|
| Septal Nuclei | 1 | 1996 | 84 | 0.010 |
Why?
|
| Automation | 1 | 1998 | 588 | 0.010 |
Why?
|
| Receptor, EphA8 | 1 | 1995 | 4 | 0.010 |
Why?
|
| Receptor, EphB4 | 1 | 1996 | 39 | 0.010 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 1 | 1995 | 36 | 0.010 |
Why?
|
| Models, Structural | 1 | 1996 | 340 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9508 | 0.010 |
Why?
|
| Kinesis | 1 | 1994 | 2 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1996 | 424 | 0.010 |
Why?
|
| Vision Tests | 1 | 1995 | 160 | 0.010 |
Why?
|
| Polysomnography | 1 | 2001 | 1865 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1996 | 521 | 0.010 |
Why?
|
| Wakefulness | 1 | 2001 | 1283 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2008 | 65365 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 3349 | 0.010 |
Why?
|
| Papilledema | 1 | 1995 | 130 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 1995 | 200 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 1997 | 395 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 2392 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 1337 | 0.010 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1996 | 254 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 1997 | 591 | 0.010 |
Why?
|
| Vitrectomy | 1 | 1997 | 392 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 6993 | 0.010 |
Why?
|
| Genotype | 2 | 2000 | 13038 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2000 | 2604 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8198 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 18047 | 0.010 |
Why?
|
| Manometry | 1 | 1995 | 459 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1996 | 962 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 8051 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 1833 | 0.010 |
Why?
|
| Syndrome | 1 | 1998 | 3275 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 4622 | 0.010 |
Why?
|
| Mathematics | 1 | 1993 | 704 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 1972 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 4120 | 0.010 |
Why?
|
| Fibrosis | 1 | 1998 | 2076 | 0.010 |
Why?
|
| Retinitis | 1 | 1990 | 36 | 0.010 |
Why?
|
| Iris Diseases | 1 | 1990 | 36 | 0.010 |
Why?
|
| Software | 1 | 1984 | 4452 | 0.010 |
Why?
|
| Solubility | 1 | 1992 | 1085 | 0.010 |
Why?
|
| Fetus | 1 | 1997 | 1883 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1996 | 3092 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1992 | 406 | 0.010 |
Why?
|
| Collagen | 1 | 1998 | 2646 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1985 | 6317 | 0.000 |
Why?
|
| Pregnancy | 2 | 2004 | 30198 | 0.000 |
Why?
|
| Pain, Postoperative | 1 | 1999 | 1764 | 0.000 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1998 | 1812 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 3811 | 0.000 |
Why?
|
| Knee Joint | 1 | 1997 | 1686 | 0.000 |
Why?
|
| Gestational Age | 1 | 1997 | 3615 | 0.000 |
Why?
|
| Adaptation, Physiological | 1 | 1994 | 1315 | 0.000 |
Why?
|
| Linear Models | 1 | 1997 | 5878 | 0.000 |
Why?
|
| Placenta | 1 | 1996 | 1722 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1998 | 3334 | 0.000 |
Why?
|
| Differential Threshold | 1 | 1986 | 80 | 0.000 |
Why?
|
| Corneal Diseases | 1 | 1990 | 535 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4981 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1996 | 3407 | 0.000 |
Why?
|
| Depression | 1 | 2001 | 8241 | 0.000 |
Why?
|
| Lacrimal Apparatus | 1 | 1983 | 223 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1997 | 42654 | 0.000 |
Why?
|
| Prednisone | 1 | 1983 | 1568 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1984 | 2363 | 0.000 |
Why?
|
| Child | 3 | 1997 | 80894 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1997 | 26410 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1997 | 41791 | 0.000 |
Why?
|